Anti-Lin28B antibody [EPR18717]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(15 Publications)
Rabbit Recombinant Monoclonal Lin28B antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Recombinant full length protein - Human samples. Cited in 15 publications.
View Alternative Names
CSDD2, LIN28B, Protein lin-28 homolog B, Lin-28B
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-Lin28B antibody [EPR18717] (AB191881)
ab191881 staining Lin28B in wild-type HEK293 cells (top panel) and Lin28B knockout HEK293 cells (bottom panel). The cells were fixed with 4% paraformaldehyde (10 min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab191881 at 10μg/ml and ab7291 (Mouse monoclonal to alpha Tubulin) at 1/1000 dilution overnight at +4°C, followed by a further incubation at room temperature for 1h with a goat secondary antibody to rabbit IgG (Alexa Fluor® 488) (ab150081) at 2 μg/ml (shown in green) and a goat secondary antibody to mouse IgG (Alexa Fluor® 594) (ab150120) at 2 μg/ml (shown in pseudo color red). Nuclear DNA was labelled in blue with DAPI.
Image was taken with a high-content analysis system (Perkin Elmer, Operetta CLS™).
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Lin28B antibody [EPR18717] (AB191881)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized JAR (Human placenta choriocarcinoma cell line) cells labeling Lin28B with ab191881 at 1/1000 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasm and nuclear staining on JAR cells. The nuclear counter stain is DAPI (blue). Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution (red).
The negative controls are as follows :
-ve control 1 : ab191881 at 1/1000 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution.
-ve control 2 : ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/1000 dilution.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Lin28B antibody [EPR18717] (AB191881)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized K562 (Human chronic myelogenous leukemia cells from bone marrow) cells labeling Lin28B with ab191881 at 1/1000 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasm and nuclear staining on K562 cells. The nuclear counter stain is DAPI (blue). Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution (red).
The negative controls are as follows :
-ve control 1 : ab191881 at 1/1000 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution.
-ve control 2 : ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/1000 dilution.
- WB
Lab
Western blot - Anti-Lin28B antibody [EPR18717] (AB191881)
Lanes 1 - 4 : Merged signal (red and green). Green - ab191881 observed at 35 kDa. Red - loading control ab7291 (Mouse anti-Alpha Tubulin [DM1A]) observed at 55 kDa.
ab191881 was shown to react with Lin28B in wild-type HEK-293 cells in Western blot with loss of signal observed in LIN28B knockout sample. Wild-type HEK-293 and LIN28B knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with ab191881 and ab7291 (Mouse anti-Alpha Tubulin [DM1A]) overnight at 4°C at a 1 in 2000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-Lin28B antibody [EPR18717] (ab191881) at 1/2000 dilution
Lane 1:
Wild-type HEK293 cell lysate at 20 µg
Lane 2:
LIN28B knockout HEK293 cell lysate at 20 µg
Lane 3:
HepG2 cell lysate at 20 µg
Lane 4:
K562 cell lysate at 20 µg
Predicted band size: 27 kDa
Observed band size: 35 kDa
false
- WB
Supplier Data
Western blot - Anti-Lin28B antibody [EPR18717] (AB191881)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Lin28B antibody [EPR18717] (ab191881) at 1/2000 dilution
All lanes:
Human testis lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 27 kDa
Observed band size: 30 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-Lin28B antibody [EPR18717] (AB191881)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Lin28B antibody [EPR18717] (ab191881) at 1/2000 dilution
Lane 1:
K562 (Human chronic myelogenous leukemia cells from bone marrow) whole cell lysate at 20 µg
Lane 2:
HepG2 (Human liver hepatocellular carcinoma) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 27 kDa
Observed band size: 30 kDa
false
Exposure time: 5s
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-Lin28B antibody [EPR18717] (AB191881)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed K562 (Human chronic myelogenous leukemia cells from bone marrow) cells labeling Lin28B with ab191881 at 1/150 dilution (red) compared with a rabbit monoclonal IgG isotype control (ab172730; black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti rabbit IgG (FITC) at 1/500 dilution was used as the secondary antibody.
- IP
Supplier Data
Immunoprecipitation - Anti-Lin28B antibody [EPR18717] (AB191881)
Lin28B was immunoprecipitated from 1mg of K562 (Human chronic myelogenous leukemia cells from bone marrow) whole cell lysate with ab191881 at 1/50 dilution. Western blot was performed from the immunoprecipitate using ab191881 at 1/1000 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.
Lane 1 : K562 whole cell lysate 10ug (Input).
Lane 2 : ab191881 IP in K562 whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab191881 in K562 whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 5 seconds.
All lanes:
Immunoprecipitation - Anti-Lin28B antibody [EPR18717] (ab191881)
Predicted band size: 27 kDa
false
- WB
Lab
Western blot - Anti-Lin28B antibody [EPR18717] (AB191881)
Lanes 1-4 : Merged signal (red and green). Green - ab191881 observed at 36 kDa. Red - loading control ab7291 observed at 50 kDa.
ab191881 Anti-Lin28B antibody [EPR18717] was shown to specifically react with Lin28B in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab265066 (knockout cell lysate ab257504) was used. Wild-type and Lin28B knockout samples were subjected to SDS-PAGE. ab191881 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Lin28B antibody [EPR18717] (ab191881) at 1/1000 dilution
Lane 1:
Wild-type HEK293T cell lysate at 20 µg
Lane 2:
LIN28B knockout HEK293T cell lysate at 20 µg
Lane 2:
Western blot - Human LIN28B knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-lin28b-knockout-hek-293t-cell-line-ab265066'>ab265066</a>)
Lane 3:
HepG2 cell lysate at 20 µg
Lane 4:
SW480 cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 27 kDa
Observed band size: 36 kDa
false
- WB
Supplier Data
Western blot - Anti-Lin28B antibody [EPR18717] (AB191881)
Blocking/Dilution buffer : 5% NFDM/TBST.
Recombinant Human Lin28B protein contains aa1-250 with His-Tag®.
All lanes:
Western blot - Anti-Lin28B antibody [EPR18717] (ab191881) at 1/2000 dilution
All lanes:
Recombinant full length Human Lin28B protein at 0.01 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 27 kDa
false
Exposure time: 1s
- WB
Supplier Data
Western blot - Anti-Lin28B antibody [EPR18717] (AB191881)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Lin28B antibody [EPR18717] (ab191881) at 1/2000 dilution
All lanes:
NCCIT (Human pluripotent embryonic carcinoma) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 27 kDa
Observed band size: 30 kDa
false
Exposure time: 15s
- WB
Supplier Data
Western blot - Anti-Lin28B antibody [EPR18717] (AB191881)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Lin28B antibody [EPR18717] (ab191881) at 1/2000 dilution
All lanes:
Human placenta lysate at 20 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 27 kDa
Observed band size: 30 kDa
false
Exposure time: 3min
Related conjugates and formulations (1)
-
Anti-Lin28B antibody [EPR18717] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (15)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:2863 PubMed40128181
2025
Applications
Unspecified application
Species
Unspecified reactive species
JCI insight 8: PubMed37991019
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:6885 PubMed37898598
2023
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 26:528 PubMed37869644
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 27:1384-1397 PubMed37005492
2023
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:7564-7578 PubMed35282771
2022
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 16:e0255971 PubMed34424910
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 23: PubMed34227673
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancer biology & therapy 22:311-323 PubMed33879018
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy. Nucleic acids 23:552-564 PubMed33510943
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com